Key clinical point: High-intensity focused ultrasound (HIFU) for the treatment of symptomatic uterine fibroids demonstrated superior outcomes in terms of symptomatic relief, improvement in quality of life (QoL), recovery, and complications compared with surgery.
Major finding: Compared with the surgery group, the HIFU group demonstrated a greater reduction in uterine fibroid severity score at 6- and 12-month follow-up ( P less than .05), greater increase in QoL score at 6- and 12-month follow-up ( P < .05), and shorter duration of hospital stay and return to work ( P less than .05). Differences in adverse events, symptom recurrence, reintervention, and pregnancy between the groups were not significant ( P greater than .05).
Study details: The data come from a meta-analysis of 10 studies involving 4,450 women.
Disclosures: The study did not receive any funding. The authors declared no conflict of interests.
Source: Liu L et al. Eur Radiol. 2021 Aug 1. doi: 10.1007/s00330-021-08156-6 .